Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Saffie

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Drug Targeting|January 1, 1996
High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiencyG Gregoriadis, R Saffie, S L Hart
FEBS Letters|February 3, 1997
Liposome-mediated DNA vaccinationG Gregoriadis, R Saffie, J B de Souza
Methods (San Diego, Calif.)|October 20, 1999
Vaccine entrapment in liposomesG Gregoriadis, B McCormack, M Obrenovic, et al.
Urologia Internationalis|March 29, 2002
Comparative study of peptides isolated from class I antigen groove of urological specimens. a further step toward the future of peptide therapy in bladder cancer patientsN Torabi-Pour, A M E Nouri, R Saffie, et al.
Urologia Internationalis|January 23, 2002
Comparative study between direct mild acid extraction and immunobead purification technique for isolation of HLA class I-associated peptidesN Torabi-Pour, A M E Nouri, R Saffie, et al.
Hepatology (Baltimore, Md.)|October 31, 1998
Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infectionP N Soni, D Brown, R Saffie, et al.
Urologia Internationalis|October 10, 2002
Isolation of human leukocyte antigen (HLA)-associated peptide(s) in the absence of HLA-restricted specific cytolytic T lymphocytesN Torabi-Pour, A M E Nouri, R Saffie, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2020
Topical siRNA delivery to the cornea and anterior eye by hybrid silicon-lipid nanoparticlesPaulina Baran-Rachwalska, Nissim Torabi-Pour, Flavia Maria Sutera, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 19, 2025
Topical mutant allele-specific siRNA delivery for treatment of Meesmann epithelial corneal dystrophy and elucidation of disease biomarkersAndrew McLain, Suzanne R Saffie-Siebert, Nadia Sukusu Nielsen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Drug Targeting|January 1, 1996
High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiencyG Gregoriadis, R Saffie, S L Hart
FEBS Letters|February 3, 1997
Liposome-mediated DNA vaccinationG Gregoriadis, R Saffie, J B de Souza
Methods (San Diego, Calif.)|October 20, 1999
Vaccine entrapment in liposomesG Gregoriadis, B McCormack, M Obrenovic, et al.
Urologia Internationalis|March 29, 2002
Comparative study of peptides isolated from class I antigen groove of urological specimens. a further step toward the future of peptide therapy in bladder cancer patientsN Torabi-Pour, A M E Nouri, R Saffie, et al.
Urologia Internationalis|January 23, 2002
Comparative study between direct mild acid extraction and immunobead purification technique for isolation of HLA class I-associated peptidesN Torabi-Pour, A M E Nouri, R Saffie, et al.
Hepatology (Baltimore, Md.)|October 31, 1998
Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infectionP N Soni, D Brown, R Saffie, et al.
Urologia Internationalis|October 10, 2002
Isolation of human leukocyte antigen (HLA)-associated peptide(s) in the absence of HLA-restricted specific cytolytic T lymphocytesN Torabi-Pour, A M E Nouri, R Saffie, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2020
Topical siRNA delivery to the cornea and anterior eye by hybrid silicon-lipid nanoparticlesPaulina Baran-Rachwalska, Nissim Torabi-Pour, Flavia Maria Sutera, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 19, 2025
Topical mutant allele-specific siRNA delivery for treatment of Meesmann epithelial corneal dystrophy and elucidation of disease biomarkersAndrew McLain, Suzanne R Saffie-Siebert, Nadia Sukusu Nielsen, et al.
Pageof 1